CY1120566T1 - Συνθεση για μειωση της απορροφησης διατροφικου λιπους - Google Patents

Συνθεση για μειωση της απορροφησης διατροφικου λιπους

Info

Publication number
CY1120566T1
CY1120566T1 CY20181100749T CY181100749T CY1120566T1 CY 1120566 T1 CY1120566 T1 CY 1120566T1 CY 20181100749 T CY20181100749 T CY 20181100749T CY 181100749 T CY181100749 T CY 181100749T CY 1120566 T1 CY1120566 T1 CY 1120566T1
Authority
CY
Cyprus
Prior art keywords
composition
fat absorption
compositions
nutritional fat
reduce nutritional
Prior art date
Application number
CY20181100749T
Other languages
English (en)
Inventor
Pee Win Chong
Thomas Hafner
Istvan Puskas
Original Assignee
Omega Pharma Innovation & Development Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omega Pharma Innovation & Development Nv filed Critical Omega Pharma Innovation & Development Nv
Publication of CY1120566T1 publication Critical patent/CY1120566T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28—Substances of animal origin, e.g. gelatin or collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Αυτή η εφεύρεση αναφέρεται σε συνθέσεις για μείωση της απορρόφησης ή της βιοδιαθεσιμότητας των λιπιδίων στην γαστρεντερική οδό και σε μεθόδους για την παρασκευή και χρήση αυτών των συνθέσεων. Οι συνθέσεις περιλαμβάνουν μια πηγή διατροφικών ινών μαζί με μια κυκλοδεξτρίνη. Οι συνθέσεις της εφεύρεσης είναι κατάλληλες για χρήση στην πρόληψη και θεραπεία της παχυσαρκίας ή της υπερλιπιδαιμίας.
CY20181100749T 2010-05-14 2018-07-18 Συνθεση για μειωση της απορροφησης διατροφικου λιπους CY1120566T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MYPI2010002277 2010-05-14
US38973210P 2010-10-05 2010-10-05
PCT/MY2011/000044 WO2011142652A1 (en) 2010-05-14 2011-05-13 Composition for reducing absorption of dietary fat

Publications (1)

Publication Number Publication Date
CY1120566T1 true CY1120566T1 (el) 2019-07-10

Family

ID=44453774

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100749T CY1120566T1 (el) 2010-05-14 2018-07-18 Συνθεση για μειωση της απορροφησης διατροφικου λιπους

Country Status (20)

Country Link
US (3) US9107441B2 (el)
EP (1) EP2568827B1 (el)
CN (1) CN103096738B (el)
AU (1) AU2011251041B2 (el)
CA (1) CA2799397C (el)
CY (1) CY1120566T1 (el)
DK (1) DK2568827T3 (el)
ES (1) ES2679276T3 (el)
HR (1) HRP20181142T1 (el)
HU (1) HUE038907T2 (el)
LT (1) LT2568827T (el)
MX (1) MX336016B (el)
MY (1) MY161578A (el)
PL (1) PL2568827T3 (el)
RS (1) RS57468B1 (el)
RU (1) RU2566050C2 (el)
SI (1) SI2568827T1 (el)
TR (1) TR201810187T4 (el)
WO (1) WO2011142652A1 (el)
ZA (1) ZA201209494B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014064505A (ja) * 2012-09-25 2014-04-17 Fujifilm Corp 食品用組成物および脂質吸収抑制剤
CN103416823B (zh) * 2013-08-20 2015-01-21 浙江诺特健康科技股份有限公司 一种塑身固体饮料
CN105622538B (zh) * 2014-10-27 2019-02-01 中国医学科学院药物研究所 一锅法高收率制备新利司他
CN105029427A (zh) * 2015-06-10 2015-11-11 刘兆君 一种减肥饮片及其制备方法
US11026446B2 (en) * 2015-12-22 2021-06-08 Mccormick & Company, Incorporated High integrity encapsulation product
CN107114787B (zh) * 2017-05-09 2020-11-13 宝健（北京）生物技术有限公司 一种阻止热量吸收的组合物
CN112826872A (zh) * 2021-01-15 2021-05-25 尼腾(广州)生物科技有限公司 一种胃肠排毒、减肥的组合物及其应用
CN115104733A (zh) * 2021-03-18 2022-09-27 南京壹盛康品生物科技有限公司 α-环糊精在制备降脂食品、保健品及药物中的应用
CN114903175A (zh) * 2022-05-31 2022-08-16 威海紫光优健科技股份有限公司 一种膳食营养补充品及制备工艺

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
JPH03139266A (ja) * 1989-10-24 1991-06-13 Nippon Kayaku Co Ltd ポタージュ
JPH078223A (ja) * 1993-06-25 1995-01-13 Les-Bensu Furoide:Kk クチナシエキスを含有する健康飲料
KR950030864A (ko) * 1994-05-10 1995-12-18 이상수 고온에서 압출 성형한 식이섬유가 풍부한 저칼로리 다이어트 식품
US20030092673A1 (en) * 1997-02-06 2003-05-15 Henryk Struszczyk Substance and method for reduction of lipids and cholesterol
JP2987581B1 (ja) * 1998-08-31 1999-12-06 株式会社環境システム 健康食品
WO2001032038A1 (en) 1999-10-29 2001-05-10 Hunza Di Pistolesi Elvira E C. S.A.S. Fibrous-liponutritional complexes and compositions containing them
ES2240516T3 (es) * 2000-07-28 2005-10-16 F. Hoffmann-La Roche Ag Nuevo uso de los inhibidores de lipasa.
FR2823423B1 (fr) 2001-04-11 2004-08-27 Bio Serae Laboratoires Preparation a base de cactaceae ayant la propriete de fixer les graisses, et procede d'obtention d'une telle preparation
JP2002371001A (ja) * 2001-06-18 2002-12-26 Nagase & Co Ltd 白内障の予防または治療剤
US20030232068A1 (en) * 2002-06-14 2003-12-18 Lewandowski Daniel J. Food product having increased bile acid binding capacity
CA2677430C (en) * 2002-08-19 2014-02-18 Art Jen Complexus, Inc. Compositions comprising dietary fat complexer and methods for their use
US20040116382A1 (en) 2002-12-13 2004-06-17 Plank David W. Food products containing cyclodextrins having beneficial hypocholesterolemic effects and method of making and communicating the benefit of such products
CN1423961A (zh) * 2002-12-26 2003-06-18 上海德生生物科技有限公司 壳聚糖保健食品及其制备方法
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
EP1447014A1 (en) * 2003-02-14 2004-08-18 Wacker-Chemie GmbH Method for reducing the glycemic index for food
WO2006004574A2 (en) * 2004-02-19 2006-01-12 Abbott Laboratories Method for using gamma cyclodextrin to control blood glucose and insulin secretion
CN100508790C (zh) * 2004-08-06 2009-07-08 吉林省吉鹤燕麦有限公司 活力燕麦纤维素口嚼片及制造方法
CN1759748A (zh) * 2005-10-19 2006-04-19 中国食品发酵工业研究院 白灵菇营养糊冲剂及其生产方法
MY144556A (en) * 2005-10-24 2011-09-30 Nestec Sa Dietary fiber formulation and method of administration
JP2007284366A (ja) 2006-04-14 2007-11-01 Kaneka Corp 脂質吸収阻害剤およびその摂取方法
KR20070112319A (ko) 2006-05-20 2007-11-23 심상열 적색 단무지의 제조방법
CN101953390A (zh) * 2009-07-13 2011-01-26 景福民 一种仙人掌保健面包
CN101669578B (zh) * 2009-09-24 2011-09-21 北京福乐维生物技术有限公司 一种畜禽营养补充剂及其制备方法

Also Published As

Publication number Publication date
US9107441B2 (en) 2015-08-18
SI2568827T1 (sl) 2018-10-30
DK2568827T3 (en) 2018-07-30
ZA201209494B (en) 2016-08-31
RU2566050C2 (ru) 2015-10-20
TR201810187T4 (tr) 2018-08-27
US20130059817A1 (en) 2013-03-07
PL2568827T3 (pl) 2018-10-31
RU2012154014A (ru) 2014-06-20
MY161578A (en) 2017-04-28
CA2799397C (en) 2016-10-04
CN103096738A (zh) 2013-05-08
AU2011251041B2 (en) 2016-01-14
CN103096738B (zh) 2015-12-16
AU2011251041A1 (en) 2012-09-27
HRP20181142T1 (hr) 2018-09-21
RS57468B1 (sr) 2018-09-28
LT2568827T (lt) 2018-08-27
US20160051574A1 (en) 2016-02-25
MX2012012389A (es) 2013-03-21
HUE038907T2 (hu) 2018-12-28
MX336016B (es) 2016-01-06
EP2568827B1 (en) 2018-04-25
WO2011142652A1 (en) 2011-11-17
EP2568827A1 (en) 2013-03-20
US20180325941A1 (en) 2018-11-15
WO2011142652A8 (en) 2012-02-02
CA2799397A1 (en) 2011-11-17
ES2679276T3 (es) 2018-08-23

Similar Documents

Publication Publication Date Title
CY1120566T1 (el) Συνθεση για μειωση της απορροφησης διατροφικου λιπους
CY1123126T1 (el) Συνθεσεις για την αγωγη γαστρεντερικης φλεγμονης
CY1123883T1 (el) Ανθρωποποιημενα αντισωματα κατα της liv-1 και χρηση αυτων για τη θεραπευτικη αντιμετωπιση του καρκινου
CY1119070T1 (el) Διαμορφωση της εκφρασης τρανσθυρετινης
CY1118014T1 (el) Aνti-il-23 αντισωματα
CY1124412T1 (el) Aνti-dkk-1 αντισωματα
CY1117582T1 (el) Χρηση μιμοτοπων των α-συνουκλεϊνης επιτοπων για θεραπεια ασθενειων σωματος lewy
CY1116264T1 (el) Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2
CY1121167T1 (el) Βελτιωμενα αντισωματα εναντι της ανθρωπινης φρακταλκινης και χρησεις αυτων
CY1113640T1 (el) Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας
IL225371A0 (en) Focoxim conjugates are useful for the treatment of pathologies related to 90hsp
CY1118254T1 (el) Αντισωματα toy βμρ-6
BRPI1010609A2 (pt) composições de cura de umidade com intensidade inicial aprimorada.
ES1073379Y (es) Camilla plegable de estructura ligera
CY1123279T1 (el) Κορτικοστεροειλη για τη θεραπεια φλεγμονωδων παθησεων της γαστρεντερικης οδου
CY1118967T1 (el) Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
CY1113065T1 (el) Συνθεσεις flupentixol
CY1123049T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
DK2411043T3 (da) Behandling af cancer med immunostimulatorisk hiv tat derivat-polypeptider
BRPI1006886A2 (pt) anel gástrico com haste ajustável
FI20096192A (fi) Kohteen valaiseminen
IT1406152B1 (it) Fullerene funzionalizzato con gruppi ossazolinici o diidroossazinici
FI20105970A0 (fi) Parannettu ravintokorvaus syövän hoitamiseksi ja ehkäisemiseksi
CY1120931T1 (el) Συνθεσεις διπροπιονικης βεκλομεθαζονης σε τροποποιημενης-απελευθερωσης γαστρο-ανθεκτικες μικροσφαιρες
CY1115158T1 (el) Ραδιοανοσοσυζευγματα και χρησεις αυτων